News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KREHER NERISSA
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 9,280 shares
@ $15.0876, valued at
$140k
Sold 1,000 shares
@ $16.0117, valued at
$16k
Sold 68 shares
@ $16.82, valued at
$1.1k
Sold 9,464 shares
@ $14.7432, valued at
$139.5k
Sold 6,898 shares
@ $14.1376, valued at
$97.5k
Exercised 10,348 options to buy
@ $2.1, valued at
$21.7k
Exercised 9,464 options to buy
@ $2.1, valued at
$19.9k
Exercised 6,898 options to buy
@ $2.1, valued at
$14.5k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/03/2023 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 5,200 shares
@ $13.4484, valued at
$69.9k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,768 shares
@ $15.2206, valued at
$42.1k
Sold 300 shares
@ $16.33, valued at
$4.9k
Sold 2,403 shares
@ $15.3096, valued at
$36.8k
Sold 3,122 shares
@ $15.2497, valued at
$47.6k
Exercised 3,068 options to buy
@ $2.1, valued at
$6.4k
Exercised 2,403 options to buy
@ $2.1, valued at
$5k
Exercised 3,122 options to buy
@ $2.1, valued at
$6.6k
|
|
| 09/23/2022 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 3,341 shares
@ $15.0833, valued at
$50.4k
Sold 939 shares
@ $15.0871, valued at
$14.2k
Exercised 3,341 options to buy
@ $2.1, valued at
$7k
Exercised 939 options to buy
@ $2.1, valued at
$2k
|
|
| 09/19/2022 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 106 shares
@ $15.0134, valued at
$1.6k
Exercised 106 options to buy
@ $2.1, valued at
$222.6 |
|
| 09/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 72,012 options to buy
@ $20, valued at
$1.4M
|
|
| 10/28/2021 |
3
| KREHER NERISSA (Chief Medical Officer) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 07/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2018 |
3
| KREHER NERISSA (Chief Medical Officer) has filed a Form 3 on AVROBIO, Inc. |
|
|